170 related articles for article (PubMed ID: 31861351)
1. P-MAPA and Interleukin-12 Reduce Cell Migration/Invasion and Attenuate the Toll-Like Receptor-Mediated Inflammatory Response in Ovarian Cancer SKOV-3 Cells: A Preliminary Study.
Lupi LA; Delella FK; Cucielo MS; Romagnoli GG; Kaneno R; Nunes IDS; Domeniconi RF; Martinez M; Martinez FE; Fávaro WJ; Chuffa LGA
Molecules; 2019 Dec; 25(1):. PubMed ID: 31861351
[TBL] [Abstract][Full Text] [Related]
2. P-MAPA immunotherapy potentiates the effect of cisplatin on serous ovarian carcinoma through targeting TLR4 signaling.
de Almeida Chuffa LG; de Moura Ferreira G; Lupi LA; da Silva Nunes I; Fávaro WJ
J Ovarian Res; 2018 Jan; 11(1):8. PubMed ID: 29343281
[TBL] [Abstract][Full Text] [Related]
3. P-MAPA activates TLR2 and TLR4 signaling while its combination with IL-12 stimulates CD4+ and CD8+ effector T cells in ovarian cancer.
Silveira HS; Lupi LA; Romagnoli GG; Kaneno R; da Silva Nunes I; Fávaro WJ; de Almeida Chuffa LG
Life Sci; 2020 Aug; 254():117786. PubMed ID: 32433918
[TBL] [Abstract][Full Text] [Related]
4. Melatonin attenuates the TLR4-mediated inflammatory response through MyD88- and TRIF-dependent signaling pathways in an in vivo model of ovarian cancer.
Chuffa LG; Fioruci-Fontanelli BA; Mendes LO; Ferreira Seiva FR; Martinez M; Fávaro WJ; Domeniconi RF; Pinheiro PF; Delazari Dos Santos L; Martinez FE
BMC Cancer; 2015 Feb; 15():34. PubMed ID: 25655081
[TBL] [Abstract][Full Text] [Related]
5. Increased toll-like receptors and p53 levels regulate apoptosis and angiogenesis in non-muscle invasive bladder cancer: mechanism of action of P-MAPA biological response modifier.
Garcia PV; Seiva FR; Carniato AP; de Mello Júnior W; Duran N; Macedo AM; de Oliveira AG; Romih R; Nunes Ida S; Nunes Oda S; Fávaro WJ
BMC Cancer; 2016 Jul; 16():422. PubMed ID: 27389279
[TBL] [Abstract][Full Text] [Related]
6. P-MAPA and IL-12 Differentially Regulate Proteins Associated with Ovarian Cancer Progression: A Proteomic Study.
Júnior LAL; Cucielo MS; Domeniconi RF; Dos Santos LD; Silveira HS; da Silva Nunes I; Martinez M; Martinez FE; Fávaro WJ; Chuffa LGA
ACS Omega; 2019 Dec; 4(26):21761-21777. PubMed ID: 31891054
[TBL] [Abstract][Full Text] [Related]
7. P-MAPA, a Fungi-Derived Immunomodulatory Compound, Induces a Proinflammatory Response in a Human Whole Blood Model.
Gonçalves MT; Squaiella-Baptistão CC; Pidde G; Lopes PH; da Silva Nunes I; Tambourgi DV
Mediators Inflamm; 2020; 2020():8831389. PubMed ID: 33299378
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-10 and prostaglandin E2 have complementary but distinct suppressive effects on Toll-like receptor-mediated dendritic cell activation in ovarian carcinoma.
Brencicova E; Jagger AL; Evans HG; Georgouli M; Laios A; Attard Montalto S; Mehra G; Spencer J; Ahmed AA; Raju-Kankipati S; Taams LS; Diebold SS
PLoS One; 2017; 12(4):e0175712. PubMed ID: 28410380
[TBL] [Abstract][Full Text] [Related]
9. Alterations in ubiquitin ligase Siah-2 and its corepressor N-CoR after P-MAPA immunotherapy and anti-androgen therapy: new therapeutic opportunities for non-muscle invasive bladder cancer.
Garcia PV; Apolinário LM; Böckelmann PK; da Silva Nunes I; Duran N; Fávaro WJ
Int J Clin Exp Pathol; 2015; 8(5):4427-43. PubMed ID: 26191134
[TBL] [Abstract][Full Text] [Related]
10. Expression and function of Toll-like receptors in peripheral blood mononuclear cells from patients with ovarian cancer.
Zhang X; Xu J; Ke X; Zhang S; Huang P; Xu T; Huang L; Lou J; Shi X; Sun R; Wang F; Pan S
Cancer Immunol Immunother; 2015 Mar; 64(3):275-86. PubMed ID: 25376541
[TBL] [Abstract][Full Text] [Related]
11. WNT5A-ROR2 is induced by inflammatory mediators and is involved in the migration of human ovarian cancer cell line SKOV-3.
Arabzadeh S; Hossein G; Salehi-Dulabi Z; Zarnani AH
Cell Mol Biol Lett; 2016; 21():9. PubMed ID: 28536612
[TBL] [Abstract][Full Text] [Related]
12. Galectin-3 induces ovarian cancer cell survival and chemoresistance via TLR4 signaling activation.
Cai G; Ma X; Chen B; Huang Y; Liu S; Yang H; Zou W
Tumour Biol; 2016 Sep; 37(9):11883-11891. PubMed ID: 27059733
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C Virus NS3 Mediated Microglial Inflammation via TLR2/TLR6 MyD88/NF-κB Pathway and Toll Like Receptor Ligand Treatment Furnished Immune Tolerance.
Rajalakshmy AR; Malathi J; Madhavan HN
PLoS One; 2015; 10(5):e0125419. PubMed ID: 25965265
[TBL] [Abstract][Full Text] [Related]
14. Tobacco smoking inhibits expression of proinflammatory cytokines and activation of IL-1R-associated kinase, p38, and NF-kappaB in alveolar macrophages stimulated with TLR2 and TLR4 agonists.
Chen H; Cowan MJ; Hasday JD; Vogel SN; Medvedev AE
J Immunol; 2007 Nov; 179(9):6097-106. PubMed ID: 17947684
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor (TLR) 2-9 agonists-induced cytokines and chemokines: I. Comparison with T cell receptor-induced responses.
Ghosh TK; Mickelson DJ; Fink J; Solberg JC; Inglefield JR; Hook D; Gupta SK; Gibson S; Alkan SS
Cell Immunol; 2006 Sep; 243(1):48-57. PubMed ID: 17250816
[TBL] [Abstract][Full Text] [Related]
16. Keratinocyte chemoattractant (KC)/human growth-regulated oncogene (GRO) chemokines and pro-inflammatory chemokine networks in mouse and human ovarian epithelial cancer cells.
Son DS; Parl AK; Rice VM; Khabele D
Cancer Biol Ther; 2007 Aug; 6(8):1302-12. PubMed ID: 17712227
[TBL] [Abstract][Full Text] [Related]
17. A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells.
Gautier G; Humbert M; Deauvieau F; Scuiller M; Hiscott J; Bates EE; Trinchieri G; Caux C; Garrone P
J Exp Med; 2005 May; 201(9):1435-46. PubMed ID: 15851485
[TBL] [Abstract][Full Text] [Related]
18. Heat-killed Brucella abortus induces TNF and IL-12p40 by distinct MyD88-dependent pathways: TNF, unlike IL-12p40 secretion, is Toll-like receptor 2 dependent.
Huang LY; Aliberti J; Leifer CA; Segal DM; Sher A; Golenbock DT; Golding B
J Immunol; 2003 Aug; 171(3):1441-6. PubMed ID: 12874236
[TBL] [Abstract][Full Text] [Related]
19. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor 2 dominance over Toll-like receptor 4 in stressful conditions for its detrimental role in the heart.
Bagchi AK; Akolkar G; Mandal S; Ayyappan P; Yang X; Singal PK
Am J Physiol Heart Circ Physiol; 2017 Jun; 312(6):H1238-H1247. PubMed ID: 28432060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
